Nabriva Therapeutics Investors

15 investors on Angel Roster list Nabriva Therapeutics in their portfolio. Most are venture capital firms and private equity firms, the most common stage is Series B and the largest groups are based in the United States, Austria and China.

Investors are matched on the company name in their portfolio, so companies that share the name Nabriva Therapeutics can appear together.

Investors listed
15
With verified email
47%
Most common stage
Series B
Top location
United States

Updated October 13, 2026 · How we compile this data

Top 15 Nabriva Therapeutics investors

The most complete profiles first. Showing 15 of 15.

  • Albert ChaVerified

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareHospitalsWomen FoundedRobotics

    Portfolio: Ossium Health, Aligos Therapeutics, Olema Oncology, Synapse Biomedical and 81 more

    Verified email available

  • Mahendra ShahVerified

    Venture Capital, Private Equity Firm, Investor · United States

    Series BHealth CareHospitalsWomen FoundedRobotics

    Portfolio: Ossium Health, Aligos Therapeutics, Olema Oncology, Synapse Biomedical and 75 more

    Verified email available

  • Nathan DauVerified

    Venture Capital, Private Equity Firm, Investor · United States

    Series BHealth CareHospitalsWomen FoundedRobotics

    Portfolio: Ossium Health, Aligos Therapeutics, Olema Oncology, Synapse Biomedical and 75 more

    Verified email available

  • Oleg NodelmanVerified

    Venture Capital, Private Equity Firm · United States

    Health CareInvestment ManagementAndroidLife Science

    Portfolio: Notch Therapeutics, Magenta Therapeutics, Syros Pharmaceuticals, Eledon Pharmaceuticals and 53 more

    Verified email available

  • Qi ZhuVerified

    Venture Capital, Private Equity Firm · China

    Health CareHospitalsWomen FoundedInvestment Management

    Portfolio: Ossium Health, Aligos Therapeutics, Olema Oncology, Synapse Biomedical and 75 more

    Verified email available

  • Sarah MarriottVerified

    Venture Capital, Private Equity Firm · United States

    Health CareInvestment ManagementAndroidLife Science

    Portfolio: Notch Therapeutics, Magenta Therapeutics, Syros Pharmaceuticals, Eledon Pharmaceuticals and 53 more

    Verified email available

  • Scott PlatshonVerified

    Venture Capital, Private Equity Firm · United States

    Health CareInvestment ManagementAndroidLife Science

    Portfolio: Notch Therapeutics, Magenta Therapeutics, Syros Pharmaceuticals, Eledon Pharmaceuticals and 53 more

    Verified email available

  • Frank Kung

    Venture Capital, Founder, Private Equity Firm · United States

    Series BHealth CareHospitalsWomen FoundedInvestment Management

    Portfolio: Ossium Health, Aligos Therapeutics, Olema Oncology, Synapse Biomedical and 76 more

    Contact details available

  • Andrew Goldberg

    Venture Capital, Private Equity Firm · United States

    Health CareHospitalsWomen FoundedRobotics

    Portfolio: Ossium Health, Aligos Therapeutics, Olema Oncology, Synapse Biomedical and 75 more

    Contact details available

  • Caroline Stout

    Venture Capital, Private Equity Firm · United States

    Health CareInvestment ManagementAndroidLife Science

    Portfolio: Notch Therapeutics, Magenta Therapeutics, Syros Pharmaceuticals, Eledon Pharmaceuticals and 53 more

    Contact details available

  • Michael Pauli

    Micro VC · Austria

    Health CareTelecommunicationsCryptocurrencyLife Science

    Portfolio: AFFiRiS, Nabriva Therapeutics, Airborne Robotics, The MoonVision and 10 more

    Contact details available

  • Nina Feng

    Venture Capital, Private Equity Firm · Taiwan

    Health CareHospitalsWomen FoundedRobotics

    Portfolio: Ossium Health, Aligos Therapeutics, Olema Oncology, Synapse Biomedical and 75 more

    Contact details available

  • Norman Zhou

    Venture Capital · United States

    Health CareWomen FoundedLife ScienceInformation Technology (IT)

    Portfolio: Black Diamond Therapeutics, AveXis, Aligos Therapeutics, Tyra Biosciences and 46 more

    Contact details available

  • Patrik Cesky

    Micro VC · Austria

    Health CareTelecommunicationsCryptocurrencyLife Science

    Portfolio: AFFiRiS, Nabriva Therapeutics, Airborne Robotics, The MoonVision and 10 more

    Contact details available

  • Shan Fu

    Venture Capital, Private Equity Firm · China

    Health CareHospitalsWomen FoundedInvestment Management

    Portfolio: Ossium Health, Aligos Therapeutics, Olema Oncology, Synapse Biomedical and 75 more

    Contact details available

Frequently asked questions

How many Nabriva Therapeutics investors are on Angel Roster?

Angel Roster lists 15 Nabriva Therapeutics investors. 7 of them (47%) include a verified email address.

What types of investors are they?

The most common investor types are Venture Capital Firms (13), Private Equity Firms (12) and Micro VC Firms (2). An investor can have more than one type, for example an angel who is also a venture partner.

Which stages do Nabriva Therapeutics investors invest in?

Among those that list a stage, the most common are Series B (3) and Seed (1).

Where are Nabriva Therapeutics investors based?

Most are based in the United States (10), Austria (2) and China (2).

Which companies have Nabriva Therapeutics investors backed?

The most-backed portfolio companies among them are Metacrine (12), Revolution Medicines (9), Passage Bio (9), Aligos Therapeutics (9) and MEI Pharma (9).

How do I contact Nabriva Therapeutics investors?

Create a free Angel Roster account to search and filter all 15, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.